This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

Invention for Innovation - PDA Call 21 Stage 1 Minutes

 

Contents

Invention for Innovation (i4i) Programme

i4i Product Development Awards (PDA) C21 Stage 1 Sub-Committee Meeting

Minutes of meeting held on Thursday 4 February 2021 via Zoom Virtual Meeting

In attendance:

Sub-Committee

Mr Mark Kirby (Chair)

Mr Charles Spicer (Chair)

Professor David Hawkes (Deputy Chair)

i4i Secretariat

Mr Martin Hunt (Programme Director)

Mr Ben Patient (Director of Innovations)

Dr Ruth Nebauer (Assistant Director)

Dr Andrew Barber

Dr Sultana Choudhry

Dr Michelle Edye

Dr Aayesha Hassan

Dr Caterina Lombardo

Mrs Paula Milton

Dr Ian Newington

Ms Deimante Normantaite

Dr Sandra Nwokeoha

Dr Marie-Therese Rached

Dr Raffaella Roncone

Mr Andreas Rossos

Miss Rhanda Tajdeen

Mr Edwin Tucker

Dr Xi Ye

Mr Bryan Dar

Apologies

Professor Paul Sibbons

Observers

Dr Erika Kennington

Ms Tanya Dixey

Stage 1 applications to be invited to submit to Stage 2:

NIHR202870: Development of a System to Provide an Automatic Diagnosis for Vestibular Conditions
Outcome: Invited to submit to Stage 2

NIHR202871: Handheld Spectroscopic Eye-safe Technology for Point-of-Care Diagnostics of Traumatic Brain Injury - 'EyeTBI'
Outcome: Invited to submit to Stage 2

NIHR202877: Development of practical Smart Walking Aid Systems for evidence-informed clinical practice and real-world monitoring.
Outcome: Invited to submit to Stage 2

NIHR202878: AssistAbility: Remote frailty monitoring and virtual physiotherapy to improve physical function and reduce falls/injuries in older adults.
Outcome: Invited to submit to Stage 2

NIHR202879: Sensorised Micro-Surgical Robot for Safe Regenerative Retinal Therapy Delivery
Outcome: Invited to submit to Stage 2

NIHR202883: ViewEye: Digital platform technology for low-cost, community based retinal imaging
Outcome: Invited to submit to Stage 2

NIHR202884: Investigation of a digital health solution providing real-time inhaler technique guidance.
Outcome: Invited to submit to Stage 2

NIHR202896: Novel and Exceptional Haemostatic Medical Devices for Serious Injuries and Surgery
Outcome: Invited to submit to Stage 2

NIHR202907: PreSize Vascular medical device software to improve planning of minimally invasive aortic repairs
Outcome: Invited to submit to Stage 2

NIHR202909: CanSense-CRC : Development and optimisation of a blood test for the early detection of bowel cancer in primary care
Outcome: Invited to submit to Stage 2

NIHR202911: CognoSpeak: a Cognitive Health Assessment Tool (CcHAT)
Outcome: Invited to submit to Stage 2

NIHR202920: NeWTS: Neonatal Wireless Transmission System for Monitoring in Intensive Care
Outcome: Invited to submit to Stage 2

NIHR202921: Advanced prototype for implementing the 1-hour algorithm for troponin testing at the point of care
Outcome: Invited to submit to Stage 2

NIHR202924: Pressure ulcer prevention through pressure equalisation technology for the seated individual
Outcome: Invited to submit to Stage 2

NIHR202932: Development of a synthetic membrane (SAM) substituting human amniotic membrane (HAM) for ocular surface reconstruction.
Outcome: Invited to submit to Stage 2

NIHR202935: Can novel ureteric stents offer a better patient outcome compared to existing standard ureteric stents (CASSETTE)
Outcome: Invited to submit to Stage 2

Stage 1 applications not invited to submit to Stage 2:

NIHR202872: Quin: research, development and evaluation of the effectiveness and economic impact of a NICE Tier 3b mobile medical app for personalised self-management of type 1 diabetes
Outcome: Reject

NIHR202873: A clinical trial to assess the safety and performance of the PRIMA bionic vision system for restoration of vision in retinitis pigmentosa (PRIMA-RPFS)
Outcome: Reject

NIHR202874: Spotlight Consultations Clinical e-Tools: Efficacy, Cost-effectiveness and Commercialisation in Routine Care for Type 1 Diabetes, Type 2 Diabetes and Pre-Diabetes
Outcome: Reject

NIHR202875: Clinical Investigation of Agluna® Silver Ion Treated 3D-Printed Cranioplasty Plates
Outcome: Reject

NIHR202876: Improving patient diagnostic experience with novel automated sampling system: Potential importance for hypertension screening
Outcome: Reject

NIHR202881: Automated Asthma Assistant and voice-activated diagnostic: greater communication, interactive learning and monitoring of symptoms non-invasively as a tool for patients with all severities of asthma.
Outcome: Reject

NIHR202882: HemoGlo®: A Faecal Occult Blood Detector & Patient Navigation for Colorectal Cancer Screening.
Outcome: Reject

NIHR202885: Development and Assessment of Ostique’s Pioneering Ostomy Device on the Physical Health and Mental Wellbeing of Ostomates.
Outcome: Reject

NIHR202886: Development of a bed-side device for rapid profiling of the vaginal microbiome
Outcome: Reject

NIHR202887: Electrochemical biosensors for point of care detection of COV-SARS-2 and other microorganisms
Outcome: Reject

NIHR202888: HeartRater-Clinical: Optimising delivery of ADIE Therapy
Outcome: Reject

NIHR202889: An independent, interactive, rapid web-based platform for the non-invasive assessment of coronary heart disease
Outcome: Reject

NIHR202890: A Novel Secure Dispenser for Liquid Pharmacological Agents
Outcome: Reject

NIHR202891: Developing a rapid point of care device for diagnosing urinary tract infections (UTI).
Outcome: Reject

NIHR202892: The “Comfortable Masks Pathway”: Development of a 3D-printed mask and headgear system with concurrent development of a service pathway for NHS adoption to improve outcomes in children using non-invasive ventilation.
Outcome: Reject

NIHR202893: Combining environmental, biometric, and self-reported data to support Asthma Management
Outcome: Reject

NIHR202894: Integrated carotid and brain RF coil optimised for MRI in the diagnosis and treatment of neurovascular disease
Outcome: Reject

NIHR202895: Enabling precision medicine in Coronary Artery Disease by site-of-disease biomolecule sampling and comprehensive analysis; the BIOPATTERN trial
Outcome: Reject

NIHR202897: Development of the Leukocyte ImmunoTest(TM) System for rapid early indication and monitoring of sepsis.
Outcome: Reject

NIHR202898: wSCG: Wireless SeismoCardioGram Sensor for Arrhythmia Management
Outcome: Reject

NIHR202899: Osteophone: Vibro-acoustics apparatus and software to enable osteoporosis screening at minimum cost
Outcome: Reject

NIHR202900: Minimally Invasive Spinal Cord Stimulator (MI-SCS) for chronic pain treatment
Outcome: Reject

NIHR202901: VIRTUE2 - A VIrtual Reality based Total post-stroke rehabilitation Unit and remote monitoring following dischargE
Outcome: Reject

NIHR202902: NOVID – a NOVel patIent shielD for Dentistry
Outcome: Reject

NIHR202903: Development of a new metacarpo-phalangeal (finger) joint replacement
Outcome: Reject

NIHR202904: A translational research study to evaluate the effectiveness of a combined novel digital biomarker and smartphone-based asthma management system to improve asthma control.
Outcome: Reject

NIHR202905: Development and clinical validation of Multi-level Stimulator for use in moderate Obstructive Sleep Apnoea patients.
Outcome: Reject

NIHR202906: A novel home vital signs monitoring system with mobile app for early detection of deterioration in vulnerable patients
Outcome: Reject

NIHR202908: The accuracy of intraoral 3-Dimensional (3D) X-ray imaging using Digital Tomosynthesis (DT) in the detection and characterisation of dental caries and apical disease.
Outcome: Reject

NIHR202910: STIX (STI Diagnostics) - Development and clinical validation of an innovative low cost, accurate Point of Care diagnostic platform for Sexually Transmitted Infections
Outcome: Reject

NIHR202912: Novel Stem/Head Abrasive Redressing Kit for optimisation of total hip replacements (SHARK)
Outcome: Reject

NIHR202914: Augmented Reality for Radiotherapy Training, Preparation and Delivery
Outcome: Reject

NIHR202916: Dimensions Within Speech: Novel Voice Biomarkers to Monitor Asthma Control Remotely
Outcome: Reject

NIHR202919: Low-cost, Robust Instrument and Chemicals for High-Throughput Genetic Sensing of Human and Animal Pathogens at the Point of Sample by Minimally Trained Users.
Outcome: Reject

NIHR202922: Clinical validation of remote walk tests for cardiac patients
Outcome: Reject

NIHR202923: Regulatory bench-testing of a transformational polymeric heart valve: a key step toward a first-in-human trial to benefit patients aged 18-80 with one valve type
Outcome: Reject

NIHR202926: Rethinking ostomy appliances to deliver a technical and economical fit for purpose solution
Outcome: Reject

NIHR202927: Validation and commercialisation of an automated point-of-care device for rapid and specific diagnosis of respiratory pathogen infections
Outcome: Reject

NIHR202928: Integration of a respiratory medical device and AI-enabled software to innovate existing pathways for asthma patients
Outcome: Reject

NIHR202929: Revolutionizing Post-operative Surgical Care / Reconstruction with Ultrasound
Outcome: Reject

NIHR202931: Design refinement & pre-clinical study of a novel infection-resistant catheter
Outcome: Reject

NIHR202933: Investigation into the benefits of StoreGene's Genome-Wide Intelligence System on Familial Hypercholesterolemia care pathways
Outcome: Reject

NIHR202934: Brain-based Detection and Treatment of Chronic Pain
Outcome: Reject

NIHR202936: DiSC-ELEVEN: Digital Sickle Cell - Evaluating Live Evidence in Vaso-occlusive crisis and End organ damage prevention and interventioN
Outcome: Reject

NIHR202937: CAN-Detect: AI based early cancer detection using unstructured clinical health records
Outcome: Reject

NIHR202938: Rebuilding skin from the inside: development of a regenerative dermal scaffold
Outcome: Reject

NIHR202939: Using an online, asynchronous data collection system with a customisable clinical decision support tool to assess changes in health economics and clinical outcomes in asthmatics.
Outcome: Reject

The following Stage 1 applications did not fulfil the Programme’s eligibility criteria:

NIHR202880: Developing an integrated Home vision Testing solution for Remote Ophthalmic Consultation (HoTROC).
Outcome: Reject

NIHR202915: Development of a Radio Frequency Powered Neuromodulation device for treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)
Outcome: Reject

NIHR202917: Virtual reality (VR) software to improve healthcare practitioners and patient learning outcomes and experience around Temporomandibular Joint Disorders
Outcome: Reject

NIHR202918: MyEyeSite - Development of a patient-centric repository of rare-disease data to underpin research and improve clinical care.
Outcome: Reject

NIHR202925: VR-training platform for immersive training in endovascular and cardiac catheter treatments using patient specific data.
Outcome: Reject

NIHR202930: Ultima Thule
Outcome: Reject